Watchlist Price Alert

MediWound Ltd. (MDWD)

NASDAQ: MDWD · Real-Time Price · USD

20.58

0.16 (0.78%)

At close: Jun 16, 2025, 3:59 PM

20.49

-0.44%

After-hours: Jun 16, 2025, 04:04 PM EDT

0.78% (1D)

Bid	20
Market Cap	222.42M
Revenue (ttm)	20.22M
Net Income (ttm)	-30.22M
EPS (ttm)	-2.05
PE Ratio (ttm)	-10.04
Forward PE	-8.55
Analyst	Strong Buy

Ask	22.55
Volume	33,307
Avg. Volume (20D)	76,287
Open	20.48
Previous Close	20.42
Day's Range	20.30 - 20.95
52-Week Range	12.78 - 24.00
Beta	0.38

About MDWD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MDWD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MDWD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

MediWound shares are trading higher after the comp... Unlock content with Pro Subscription

News

3 weeks ago · seekingalpha.com

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

MediWound Ltd. (NASDAQ:MDWD ) Q1 2025 Earnings Conference Call May 21, 2025 8:30 AM ET Company Participants Dan Ferry - LifeSci Advisors Ofer Gonen - CEO Hani Luxenburg - CFO Barry Wolfenson - EVP of ...

3 weeks ago · zacks.com

MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates

MediWound (MDWD) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.39 per share a year ago.

1 month ago · seekingalpha.com

MediWound Ltd.: Undervalued High-Growth Potential

I rate MediWound a buy due to strong revenue growth, a robust pipeline, and significant undervaluation with massive upside potential. NexoBrid's commercial success and orphan drug status drive revenue...

2 months ago · seekingalpha.com

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

MediWound Ltd. (NASDAQ:MDWD ) Q4 2024 Results Conference Call March 19, 2025 8:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Ofer Gonen - Chief Executive Officer Hani Luxenburg - Chie...

2 months ago · zacks.com

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates

MediWound (MDWD) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $0.19 per share a year ago.